CKB and breast cancer: In basal breast cancer cell lines and tumors, there is an enrichment of H3K27 acetylation (Supplementary Fig. 9b) and number of ATAC-seq peaks (Supplementary Fig. 9c) at BCK loci, consistent with increased mRNA expression (Supplementary Fig. 9d–f).